企業プロフィール
ProPhase Labs 株価・ニュース・カタリスト
- ティッカー:
- PRPH
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.03 USD (-25.00%)
終値
最終更新: 2026年8月17日
—
時価総額
株価変動の要因
As of Aug 17, 2026, PRPH closed down 25.0% at $0.0300. No new same-company headline was identified in the current news window.
企業概要
事業概要
ProPhase Labs is a diagnostics and consumer-health company with exposure to testing, wellness, and specialty products. Its business is more diversified and opportunistic than a conventional biotech model.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, ProPhase sits in consumer health and diagnostics.
ビジネスモデルの特徴
The company depends on product and test adoption, commercial execution, and the ability to monetize a small portfolio of assets.
バイオ業界での位置付け
ProPhase is outside biotech proper and belongs to the consumer-diagnostics and health-products layer.
今後のカタリスト
- ProPhase Labs’ catalysts are diagnostics and consumer-health execution, plus any strategic update that clarifies the company’s next direction. Investors will care about whether the business can find a stable growth path.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。